
June 30 (Reuters) - Mira Pharmaceuticals Inc MIRA.O:
MIRA PHARMACEUTICALS INC - ANNOUNCES NEW STUDY RESULTS FOR SKNY-1 - SEC FILING
MIRA PHARMACEUTICALS INC - IN ANIMAL MODEL OF OBESITY & CRAVING USING SKNY-1 REDUCED BODY WEIGHT BY APPROXIMATELY 30% AFTER JUST SIX DAYS
MIRA PHARMACEUTICALS INC - TREATED ANIMALS WEIGH 10% LESS THAN HEALTHY CONTROLS - SEC FILING
MIRA PHARMACEUTICALS: IN UNTREATED OBESE ANIMALS, FAT BUILDUP IN THE LIVER WAS ABOUT 50% HIGHER THAN NORMAL
Source text: [ID:n0001641172-25-017046]